EPISODE · Jun 13, 2023 · 8 MIN
FDA considering a second Alzheimer's drug
from POLITICO's Pulse Check · host POLITICO
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Outside advisers to the FDA recommended that the agency grant traditional approval to the Alzheimer’s drug Leqembi. Host Ben Leonard talks with Katherine Ellen Foley about what final approval could mean for patients. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
FDA considering a second Alzheimer's drug
No transcript for this episode yet
Similar Episodes
Jun 20, 2026 ·2m
Jun 20, 2026 ·2m
Jun 15, 2026 ·3m
Jun 15, 2026 ·3m
Jun 14, 2026 ·2m
Jun 14, 2026 ·2m